Bank of Montreal
SCLN

Bank of Montreal’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Bank of Montreal’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,609
Closed -$41K – 4478
2017
Q3 		$41K Hold
3,609
– – ﹤0.01% 3305
2017
Q2 		$39K Buy
3,609
+790
+28% +$7.9K ﹤0.01% 3323
2017
Q1 		$27K Buy
2,819
+966
+52% +$9.65K ﹤0.01% 3280
2016
Q4 		$18K Sell
1,853
-610
-25% -$6.1K ﹤0.01% 3436
2016
Q3 		$25K Sell
2,463
-71
-3% -$773 ﹤0.01% 3280
2016
Q2 		$33K Buy
2,534
+681
+37% +$8.92K ﹤0.01% 3199
2016
Q1 		$20K Buy
+1,853
New +$16.5K ﹤0.01% 3414
2014
Q3 		– Sell
-1,360
Closed -$7K – 4680
2014
Q2 		$7K Buy
+1,360
New +$6.62K ﹤0.01% 4042

Bank of Montreal's SCLN Position: Q4 2017 in Review

Bank of Montreal sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 3,609 shares — an estimated $41K sold.

Bank of Montreal first reported a position in SCLN in Q2 2014 and held it in 8 quarters. The position peaked at $41K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Bank of Montreal reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Bank of Montreal sold 3,609 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $41K.
  • Bank of Montreal first reported a position in Sciclone Pharmaceuticals Inc in Q2 2014 and held it in 8 quarters.
  • Bank of Montreal's Sciclone Pharmaceuticals Inc position peaked at $41K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Bank of Montreal's 13F filing for Q4 2017, filed 16 Jan 2018.